BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/11/2017

FDA Releases Draft Guidance on Biosimilar User Fee Amendments of 2017

The FDA is announcing the availability of a draft guidance for industry regarding the implementation of the Biosimilar User Fee Amendments of 2017 and changes to policies and procedures surrounding its application.

Source: Federal Register — Food and Drug AdministrationOpen original release →